The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Role of Recombinant DNA Technology to Improve Life
Open accessAbstract
In the past century, the recombinant DNA technology was just an imagination that desirable characteristics can be improved in the living bodies by controlling the expressions of target genes. However, in recent era, this field has demonstrated unique impacts in bringing advancement in human life. By virtue of this technology, crucial proteins required for health problems and dietary purposes can be produced safely, affordably, and sufficiently. This technology has multidisciplinary applications and potential to deal with important aspects of life, for instance, improving health, enhancing food resources, and resistance to divergent adverse environmental effects. Particularly in agriculture, the genetically modified plants have augmented resistance to harmful agents, enhanced product yield, and shown increased adaptability for better survival. Moreover, recombinant pharmaceuticals are now being used confidently and rapidly attaining commercial approvals. Techniques of recombinant DNA technology, gene therapy, and genetic modifications are also widely used for the purpose of bioremediation and treating serious diseases. Due to tremendous advancement and broad range of application in the field of recombinant DNA technology, this review article mainly focuses on its importance and the possible applications in daily life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Simple and General Method for Transferring Genes into Plants
Horsch, R. B., Fry, J. E., Hoffmann, N. L., Wallroth, M., Eichholtz, D., Rogers, S. G., & Fraley, R. T. (1985) · Science · doi:10.1126/science.227.4691.1229 · Cited by 4,694
ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
Gaj, T., Gersbach, C. A., & Barbas, C. F. (2013) · Trends in Biotechnology · doi:10.1016/j.tibtech.2013.04.004 · Cited by 3,820
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699
Cancer regression in patients after transfer of genetically engineered lymphocytes
Morgan, R. A., Dudley, M. E., Wunderlich, J. R., Hughes, M. S., Yang, J. C., Sherry, R. M., Royal, R. E., Topalian, S. L., Kammula, U. S., Restifo, N. P., et al. (2006) · Science · doi:10.1126/science.1129003 · Cited by 2,603
An updated evolutionary classification of CRISPR–Cas systems
Makarova, K. S., Wolf, Y. I., Alkhnbashi, O. S., Costa, F., Shah, S. A., Saunders, S. J., Barrangou, R., Brouns, S. J. J., Charpentier, E., Haft, D. H., et al. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3569 · Cited by 2,480
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
Cavazzana-Calvo, M., Hacein-Bey, S., Basile, G. D. S., Gross, F., Yvon, E., Nusbaum, P., Selz, F., Hue, C., Certain, S., Casanova, J.-L., et al. (2000) · Science · doi:10.1126/science.288.5466.669 · Cited by 2,167
Chloroplast genomes: diversity, evolution, and applications in genetic engineering
Daniell, H., Lin, C.-S., Yu, M., & Chang, W.-J. (2016) · Genome Biology · doi:10.1186/s13059-016-1004-2 · Cited by 1,720
Adoptive immunotherapy for cancer: harnessing the T cell response
Restifo, N. P., Dudley, M. E., & Rosenberg, S. A. (2012) · Nature Reviews Immunology · doi:10.1038/nri3191 · Cited by 1,688
Robbins, P. F., Morgan, R. A., Feldman, S. A., Yang, J. C., Sherry, R. M., Dudley, M. E., Wunderlich, J. R., Nahvi, A. V., Helman, L. J., Mackall, C. L., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.2537 · Cited by 1,632
T Lymphocyte-Directed Gene Therapy for ADA − SCID: Initial Trial Results After 4 Years
Blaese, R. M., Culver, K. W., Miller, A. D., Carter, C. S., Fleisher, T., Clerici, M., Shearer, G., Chang, L., Chiang, Y., Tolstoshev, P., et al. (1995) · Science · doi:10.1126/science.270.5235.475 · Cited by 1,550
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C. C., Veres, G., Schmidt, M., Kutschera, I., Vidaud, M., Abel, U., Dal-Cortivo, L., Caccavelli, L., et al. (2009) · Science · doi:10.1126/science.1171242 · Cited by 1,508
Howe, S. J., Mansour, M. R., Schwarzwaelder, K., Bartholomae, C., Hubank, M., Kempski, H., Brugman, M. H., Pike-Overzet, K., Chatters, S. J., de Ridder, D., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35798 · Cited by 1,286
Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems
Shmakov, S., Abudayyeh, O. O., Makarova, K. S., Wolf, Y. I., Gootenberg, J. S., Semenova, E., Minakhin, L., Joung, J., Konermann, S., Severinov, K., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.008 · Cited by 1,209
Tzartos, J. S., Friese, M. A., Craner, M. J., Palace, J., Newcombe, J., Esiri, M. M., & Fugger, L. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070690 · Cited by 1,187
Gene therapy clinical trials worldwide to 2012 – an update
Ginn, S. L., Alexander, I. E., Edelstein, M. L., Abedi, M. R., & Wixon, J. (2013) · The Journal of Gene Medicine · doi:10.1002/jgm.2698 · Cited by 1,159
Toxic Heavy Metal and Metalloid Accumulation in Crop Plants and Foods
Clemens, S., & Ma, J. F. (2016) · Annual Review of Plant Biology · doi:10.1146/annurev-arplant-043015-112301 · Cited by 1,155
Sustained Correction of X-Linked Severe Combined Immunodeficiency by ex Vivo Gene Therapy
Hacein-Bey-Abina, S., Le Deist, F., Carlier, F., Bouneaud, C., Hue, C., De Villartay, J.-P., Thrasher, A. J., Wulffraat, N., Sorensen, R., Dupuis-Girod, S., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012616 · Cited by 1,058
Ott, M. G., Schmidt, M., Schwarzwaelder, K., Stein, S., Siler, U., Koehl, U., Glimm, H., Kühlcke, K., Schilz, A., Kunkel, H., et al. (2006) · Nature Medicine · doi:10.1038/nm1393 · Cited by 1,051
Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome
Aiuti, A., Biasco, L., Scaramuzza, S., Ferrua, F., Cicalese, M. P., Baricordi, C., Dionisio, F., Calabria, A., Giannelli, S., Castiello, M. C., et al. (2013) · Science · doi:10.1126/science.1233151 · Cited by 1,025
The production of recombinant pharmaceutical proteins in plants
Ma, J. K.-C., Drake, P. M. W., & Christou, P. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1177 · Cited by 960
Gut microorganisms, mammalian metabolism and personalized health care
Nicholson, J. K., Holmes, E., & Wilson, I. D. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1152 · Cited by 945
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
Liu, J., Pan, S., Hsieh, M. H., Ng, N., Sun, F., Wang, T., Kasibhatla, S., Schuller, A. G., Li, A. G., Cheng, D., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314239110 · Cited by 831
Engineering vascularized tissue
Jain, R. K., Au, P., Tam, J., Duda, D. G., & Fukumura, D. (2005) · Nature Biotechnology · doi:10.1038/nbt0705-821 · Cited by 808
Adipokines and Insulin Resistance
Rabe, K., Lehrke, M., Parhofer, K. G., & Broedl, U. C. (2008) · Molecular Medicine · doi:10.2119/2008-00058.rabe · Cited by 808
The protein kinase Pstol1 from traditional rice confers tolerance of phosphorus deficiency
Gamuyao, R., Chin, J. H., Pariasca-Tanaka, J., Pesaresi, P., Catausan, S., Dalid, C., Slamet-Loedin, I., Tecson-Mendoza, E. M., Wissuwa, M., & Heuer, S. (2012) · Nature · doi:10.1038/nature11346 · Cited by 784
Stein, S., Ott, M. G., Schultze-Strasser, S., Jauch, A., Burwinkel, B., Kinner, A., Schmidt, M., Krämer, A., Schwäble, J., Glimm, H., et al. (2010) · Nature Medicine · doi:10.1038/nm.2088 · Cited by 716
Creation of long-lasting blood vessels
Koike, N., Fukumura, D., Gralla, O., Au, P., Schechner, J. S., & Jain, R. K. (2004) · Nature · doi:10.1038/428138a · Cited by 701
Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems
Mohanraju, P., Makarova, K. S., Zetsche, B., Zhang, F., Koonin, E. V., & van der Oost, J. (2016) · Science · doi:10.1126/science.aad5147 · Cited by 671
Urban, D. J., & Roth, B. L. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124803 · Cited by 668
Hiruma, K., Gerlach, N., Sacristán, S., Nakano, R. T., Hacquard, S., Kracher, B., Neumann, U., Ramírez, D., Bucher, M., O’Connell, R. J., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.028 · Cited by 652
In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system
Maddalo, D., Manchado, E., Concepcion, C. P., Bonetti, C., Vidigal, J. A., Han, Y.-C., Ogrodowski, P., Crippa, A., Rekhtman, N., de Stanchina, E., et al. (2014) · Nature · doi:10.1038/nature13902 · Cited by 640
Mani, D., & Kumar, C. (2014) · International Journal of Environmental Science and Technology · doi:10.1007/s13762-013-0299-8 · Cited by 615
Structure of human follicle-stimulating hormone in complex with its receptor
Fan, Q. R., & Hendrickson, W. A. (2005) · Nature · doi:10.1038/nature03206 · Cited by 573
Simulation and prediction of in vivo drug metabolism in human populations from in vitro data
Rostami-Hodjegan, A., & Tucker, G. T. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2173 · Cited by 530
Gene-engineered T cells for cancer therapy
Kershaw, M. H., Westwood, J. A., & Darcy, P. K. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3565 · Cited by 505
The CRISPR-Cas immune system: Biology, mechanisms and applications
Rath, D., Amlinger, L., Rath, A., & Lundgren, M. (2015) · Biochimie · doi:10.1016/j.biochi.2015.03.025 · Cited by 471
Microbial factories for recombinant pharmaceuticals
Ferrer-Miralles, N., Domingo-Espín, J., Corchero, J. L., Vázquez, E., & Villaverde, A. (2009) · Microbial Cell Factories · doi:10.1186/1475-2859-8-17 · Cited by 465
Rapid, Sensitive Bioluminescent Reporter Technology for Naphthalene Exposure and Biodegradation
King, J. M., DiGrazia, P. M., Applegate, B. M., Burlage, R. S., Sanseverino, J., Dunbar, P., Larimer, F. W., & Sayler, G. S. (1990) · Science · doi:10.1126/science.249.4970.778 · Cited by 455
CRISPR-Cas: biology, mechanisms and relevance
Hille, F., & Charpentier, E. (2016) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2015.0496 · Cited by 442
A Candida albicans CRISPR system permits genetic engineering of essential genes and gene families
Vyas, V. K., Barrasa, M. I., & Fink, G. R. (2015) · Science Advances · doi:10.1126/sciadv.1500248 · Cited by 362
Antimicrobial enzymes: An emerging strategy to fight microbes and microbial biofilms
Thallinger, B., Prasetyo, E. N., Nyanhongo, G. S., & Guebitz, G. M. (2013) · Biotechnology Journal · doi:10.1002/biot.201200313 · Cited by 348
Food-processing enzymes from recombinant microorganisms—a review
Olempska-Beer, Z. S., Merker, R. I., Ditto, M. D., & DiNovi, M. J. (2006) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2006.05.001 · Cited by 333
Adams, C. W., Allison, D. E., Flagella, K., Presta, L., Clarke, J., Dybdal, N., McKeever, K., & Sliwkowski, M. X. (2006) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-005-0058-x · Cited by 316
Contribution of Variable Domains to the Stability of Humanized IgG1 Monoclonal Antibodies
Ionescu, R. M., Vlasak, J., Price, C., & Kirchmeier, M. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21104 · Cited by 313
Pennisi, E. (2013) · Science · doi:10.1126/science.341.6148.833 · Cited by 287
Genetic engineering of taxol biosynthetic genes in Saccharomyces cerevisiae
DeJong, J. M., Liu, Y., Bollon, A. P., Long, R. M., Jennewein, S., Williams, D., & Croteau, R. B. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.20694 · Cited by 269
Hairy Root and Its Application in Plant Genetic Engineering
Hu, Z., & Du, M. (2006) · Journal of Integrative Plant Biology · doi:10.1111/j.1744-7909.2006.00121.x · Cited by 252
Patra, A. K., Mukhopadhyay, R., Mukhija, R., Krishnan, A., Garg, L. C., & Panda, A. K. (2000) · Protein Expression and Purification · doi:10.1006/prep.1999.1179 · Cited by 236
Advanced genetic tools for plant biotechnology
Liu, W., Yuan, J. S., & Stewart Jr, C. N. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3583 · Cited by 234
The Birth of a Black Rice Gene and Its Local Spread by Introgression
Oikawa, T., Maeda, H., Oguchi, T., Yamaguchi, T., Tanabe, N., Ebana, K., Yano, M., Ebitani, T., & Izawa, T. (2015) · The Plant Cell · doi:10.1105/tpc.15.00310 · Cited by 230
Assidi, M., Dufort, I., Ali, A., Hamel, M., Algriany, O., Dielemann, S., & Sirard, M.-A. (2008) · Biology of Reproduction · doi:10.1095/biolreprod.108.067686 · Cited by 210
Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement
Aiuti, A., Vai, S., Mortellaro, A., Casorati, G., Ficara, F., Andolfi, G., Ferrari, G., Tabucchi, A., Carlucci, F., Ochs, H. D., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-423 · Cited by 209
Apel, W., & Bock, R. (2009) · Plant Physiology · doi:10.1104/pp.109.140533 · Cited by 208
Engineering cyanobacteria for direct biofuel production from CO2
Savakis, P., & Hellingwerf, K. J. (2015) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2014.09.007 · Cited by 207
Pharmaceutical Firms and the Transition to Biotechnology: A Study in Strategic Innovation
Galambos, L., & Sturchio, J. L. (1998) · Business History Review · doi:10.2307/3116278 · Cited by 203
Ripp, S., Nivens, D. E., Ahn, Y., Werner, C., Jarrell, J., Easter, J. P., Cox, C. D., Burlage, R. S., & Sayler, G. S. (2000) · Environmental Science & Technology · doi:10.1021/es9908319 · Cited by 189
Bendandi, M., Marillonnet, S., Kandzia, R., Thieme, F., Nickstadt, A., Herz, S., Fröde, R., Inogés, S., Lòpez-Dìaz de Cerio, A., Soria, E., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq256 · Cited by 189
McCormick, A. A., Reddy, S., Reinl, S. J., Cameron, T. I., Czerwinkski, D. K., Vojdani, F., Hanley, K. M., Garger, S. J., White, E. L., Novak, J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803636105 · Cited by 185
DNA maintenance in plastids and mitochondria of plants
Oldenburg, D. J., & Bendich, A. J. (2015) · Frontiers in Plant Science · doi:10.3389/fpls.2015.00883 · Cited by 183
Engineering of Therapeutic Proteins Production in Escherichia coli
Kamionka, M. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111794295693 · Cited by 177
The Engineered Chloroplast Genome Just Got Smarter
Jin, S., & Daniell, H. (2015) · Trends in Plant Science · doi:10.1016/j.tplants.2015.07.004 · Cited by 175
Recombinant DNA Technology in the Treatment of Diabetes: Insulin Analogs
Vajo, Z., Fawcett, J., & Duckworth, W. C. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.5.0442 · Cited by 172
Synthetic promoters: genetic control through cis engineering
Venter, M. (2007) · Trends in Plant Science · doi:10.1016/j.tplants.2007.01.002 · Cited by 170
Innovative production of bio-cellulose using a cell-free system derived from a single cell line
Ullah, M. W., Ul-Islam, M., Khan, S., Kim, Y., & Park, J. K. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2015.06.037 · Cited by 169
Self-citationFauser, B. C. J. M., Mannaerts, B. M. J. L., Devroey, P., Leader, A., Boime, I., & Baird, D. T. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmn065 · Cited by 161
Leang, C., Malvankar, N. S., Franks, A. E., Nevin, K. P., & Lovley, D. R. (2013) · Energy & Environmental Science · doi:10.1039/c3ee40441b · Cited by 160
Structural and physico-mechanical characterization of bio-cellulose produced by a cell-free system
Ullah, M. W., Ul‐Islam, M., Khan, S., Kim, Y., & Park, J. K. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2015.10.010 · Cited by 160
Self-citationThe genetic aspects of berries: from field to health
Mazzoni, L., Pérez-López, P., Giampieri, F., Álvarez-Suárez, J. M., Gasparrini, M., Forbes-Hernández, T. Y., Quiles, J. L., Mezzetti, B., & Battino, M. A. (2015) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.7216 · Cited by 150
The next green movement: Plant biology for the environment and sustainability
Jez, J. M., Lee, S. G., & Sherp, A. M. (2016) · Science · doi:10.1126/science.aag1698 · Cited by 147
Oono, Y., Yazawa, T., Kawahara, Y., Kanamori, H., Kobayashi, F., Sasaki, H., Mori, S., Wu, J., Handa, H., Itoh, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096946 · Cited by 140
Extended Survival of Glioblastoma Patients After Chemoprotective HSC Gene Therapy
Adair, J. E., Beard, B. C., Trobridge, G. D., Neff, T., Rockhill, J. K., Silbergeld, D. L., Mrugala, M. M., & Kiem, H. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003425 · Cited by 110
Cyanobacterial hydrogen production – A step towards clean environment
Tiwari, A., & Pandey, A. (2011) · International Journal of Hydrogen Energy · doi:10.1016/j.ijhydene.2011.09.100 · Cited by 106
The CRISPR System—Keeping Zebrafish Gene Targeting Fresh
Blackburn, P. R., Campbell, J. M., Clark, K. J., & Ekker, S. C. (2013) · Zebrafish · doi:10.1089/zeb.2013.9999 · Cited by 101
Biotech pharmaceuticals and biotherapy: an overview.
Steinberg, F. M., & Raso, J. (1998) · PubMed · Cited by 82
Lian, Z., Ma, Z., Wei, J., & Liu, H. (2011) · Process Biochemistry · doi:10.1016/j.procbio.2011.10.031 · Cited by 80
RNA-dependent DNA endonuclease Cas9 of the CRISPR system: Holy Grail of genome editing?
Gasiūnas, G., & Šikšnys, V. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.09.001 · Cited by 71
Lomedico, P. T. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.19.5798 · Cited by 71
Pregnancy outcome in Type 1 diabetes mellitus treated with insulin lispro (Humalog)
Masson, E. A., Patmore, J., Brash, P. D., Baxter, M., Caldwell, G., GALLEN, I. W., Price, P. A., Vice, P., Walker, J. D., & Lindow, S. W. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00840.x · Cited by 67
Metabolic engineering of synthetic cell-free systems: Strategies and applications
Ullah, M. W., Khattak, W. A., Ul‐Islam, M., Khan, S., & Park, J. K. (2015) · Biochemical Engineering Journal · doi:10.1016/j.bej.2015.10.023 · Cited by 67
Self-citationBIOTECHNOLOGICAL APPLICATIONS OF BACTERIAL BIOLUMINESCENCE (lux) GENES
Chatterjee, J., & Meighen, E. A. (1995) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1995.tb08711.x · Cited by 60
Viral vectors for gene therapy and gene modification approaches
Merten, O., & Gaillet, B. (2015) · Biochemical Engineering Journal · doi:10.1016/j.bej.2015.09.005 · Cited by 57
Progress of targeted genome modification approaches in higher plants
Cardi, T., & Stewart, C. N. (2016) · Plant Cell Reports · doi:10.1007/s00299-016-1975-1 · Cited by 57
The roles of traditional Chinese medicine in gene therapy
Ling, C., Wang, L., Wang, Y., Zhang, Y., Yin, Z.-F., Wang, M., & Ling, C. (2014) · Journal of Chinese Integrative Medicine · doi:10.1016/s2095-4964(14)60019-4 · Cited by 54
Yeast cell-free enzyme system for bio-ethanol production at elevated temperatures
Khattak, W. A., Ul‐Islam, M., Ullah, M. W., Yu, B., Khan, S., & Park, J. K. (2014) · Process Biochemistry · doi:10.1016/j.procbio.2013.12.019 · Cited by 53
Self-citationManufacturing of viral vectors for gene therapy: part I. Upstream processing
Merten, O.-W., Schweizer, M., Chahal, P. S., & Kamen, A. (2014) · Pharmaceutical Bioprocessing · doi:10.4155/pbp.14.16 · Cited by 45
Wang, R., Li, M., Gong, L., Hu, S., & Xiang, H. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw260 · Cited by 42
Recombinant DNA Technology in the Treatment of Diabetes: Insulin Analogs
Vajó, Z. (2001) · Endocrine Reviews · doi:10.1210/er.22.5.706 · Cited by 42
Combining virotherapy and angiotherapy for the treatment of breast cancer
Bazán‐Peregrino, M., Sainson, R. C. A., Carlisle, R. C., Thoma, C., Waters, R., Arvanitis, C., Harris, A. L., Hernández-Alcoceba, R., & Seymour, L. W. (2013) · Cancer Gene Therapy · doi:10.1038/cgt.2013.41 · Cited by 40
Khattak, W. A., Ullah, M. W., Ul‐Islam, M., Khan, S., Kim, M., Kim, Y., & Park, J. K. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-014-6154-0 · Cited by 40
Self-citationMetzger, L. E., & Raetz, C. R. H. (2009) · Biochemistry · doi:10.1021/bi901750f · Cited by 40
Macallan, D. C., Baldwin, C., Mandalia, S., Pandol-Kaljevic, V., Higgins, N., Grundy, A., & Moyle, G. J. (2008) · HIV Clinical Trials · doi:10.1310/hct0904-254 · Cited by 39
The innovative evolution of cancer gene and cellular therapies
Lam, P., Khan, G. N., Stripecke, R., Hui, K. M., Kasahara, N., Peng, K.-W., & Guinn, B. (2013) · Cancer Gene Therapy · doi:10.1038/cgt.2012.93 · Cited by 28
Méndez, C., & Salas, J. (2003) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620703106298699 · Cited by 26
Zhang, J., Tarbet, E. B., Toro, H., & Tang, D.-C. C. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.141 · Cited by 24
Liu, G., She, Q., & Garrett, R. A. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw286 · Cited by 22
Matsui, K., Togami, J., Mason, J. G., Chandler, S. F., & Tanaka, Y. (2013) · BioMed Research International · doi:10.1155/2013/182032 · Cited by 21
Sayler, G. S., Cox, C. D., Burlage, R. S., Ripp, S. A., Nivens, D. E., Werner, C. L., Ahn, Y., & Matrubutham, U. (1999) · Springer eBooks · doi:10.1007/978-1-4615-4749-5_24 · Cited by 19
Li, L.-X., Zhang, Y.-L., Zhou, L., Ke, M.-L., Chen, J.-M., Fu, X., Ye, C., Wu, J.-X., Liu, R., & Huang, W. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-257 · Cited by 18
Viral gene therapy for head and neck cancer
Hughes, J., Alusi, G., & Wang, Y. (2015) · The Journal of Laryngology & Otology · doi:10.1017/s0022215114003247 · Cited by 7
Human Macrophage Genetic Engineering
Smith, J. D. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306796 · Cited by 2
Cited by
Alternative Strategies for Microbial Remediation of Pollutants via Synthetic Biology
Jaiswal, S., & Shukla, P. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00808 · Cited by 195
Zhou, B., Zhang, T., & Wang, F. (2023) · Applied Sciences · doi:10.3390/app13148439 · Cited by 116
Hussain, M. H., Mohsin, M. Z., Zaman, W. Q., Yu, J., Zhao, X., Wei, Y., Zhuang, Y., Mohsin, A., & Guo, M. (2022) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2021.12.012 · Cited by 31
Metadata
- Authors
- Khan, S., Ullah, M. W., Siddique, R., Nabi, G., Manan, S., Yousaf, M., & Hou, H.
- Venue
- International Journal of Genomics
- Publisher
- Wiley
- Published
- 2016
- Volume
- 2016
- Pages
- 1-14
- ISSN
- 2314-436X (ISSN-L)
- 2314-4378
- OpenAlex
- W2560804344
- Cited by
- 279
- References
- 100
- FWCI
- 10.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.